Literature DB >> 23222562

Response to Dulku and de Klerk and Moriarty.

N Anand, D Wechsler.   

Abstract

Mesh：

Substances：

Year:  2012        PMID： 23222562      PMCID： PMC3574247          DOI： 10.1038/eye.2012.246

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN： 0950-222X            Impact factor:   3.775


× No keyword cloud information.
  5 in total

1.  Three-year follow-up of the tube versus trabeculectomy study.

Authors:  Chandra Sekhar Garudadri; Harsha L Rao; Sirisha Senthil
Journal:  Am J Ophthalmol       Date:  2010-04       Impact factor: 5.258

2.  Interval censoring for survival curves when reporting the results of glaucoma surgery.

Authors:  S Dulku
Journal:  Eye (Lond)       Date:  2012-12-07       Impact factor: 3.775

3.  Comment on 'deep sclerectomy with mitomycin C in eyes with failed glaucoma surgery and pseudophakia'.

Authors:  T A de Klerk; A P Moriarty
Journal:  Eye (Lond)       Date:  2012-12-07       Impact factor: 3.775

4.  A prospective randomized trial comparing intraoperative 5-fluorouracil vs mitomycin C in primary trabeculectomy.

Authors:  Darrell WuDunn; Louis B Cantor; Angelita M Palanca-Capistrano; Joni Hoop; Nishat P Alvi; Charles Finley; Vipul Lakhani; Alan Burnstein; Stephenie L Knotts
Journal:  Am J Ophthalmol       Date:  2002-10       Impact factor: 5.258

5.  Deep sclerectomy with mitomycin C in eyes with failed glaucoma surgery and pseudophakia.

Authors:  N Anand; D Wechsler
Journal:  Eye (Lond)       Date:  2011-10-07       Impact factor: 3.775
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.